These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26896722)

  • 1. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    Atherosclerosis; 2016 Apr; 247():105-10. PubMed ID: 26896722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.
    Lee MS; Jurewitz D; Zimmer R; Pessegueiro A; Bhatia R; Currier J; Yeatman L; Tobis JM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):909-14. PubMed ID: 19016467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010.
    Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    Intern Med; 2017; 56(1):1-9. PubMed ID: 28049984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.
    Kukreja N; Onuma Y; Garcia-Garcia HM; Daemen J; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jun; 2(6):534-41. PubMed ID: 19539258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Yoshikawa D; Hayashi M; Yasuda Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ J; 2012; 76(7):1609-15. PubMed ID: 22484980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions.
    Locker C; Schaff HV; Daly RC; Dearani JA; Bell MR; Frye RL; Greason KL; Stulak JM; Joyce LD; Pochettino A; Li Z; Lennon RJ; Lerman A
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):369-379.e4. PubMed ID: 27174511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Valstar G; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P;
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):18-26. PubMed ID: 21735520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
    Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents.
    Lee MS; Zimmer R; Pessegueiro A; Jurewitz D; Tobis J
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):526-30. PubMed ID: 18307230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).
    Mieres J; Fernandez-Pereira C; Risau G; Solorzano L; Pauletto R; Rodriguez-Granillo AM; Rubilar B; Stella P; Rodriguez AE
    Cardiovasc Revasc Med; 2012; 13(5):265-71. PubMed ID: 22796496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents.
    Fath-Ordoubadi F; Barac Y; Abergel E; Danzi GB; Kerner A; Nikolsky E; Halabi M; Mamas M; El-Omar M; Fraser D; Roguin A
    Am J Cardiol; 2012 Sep; 110(5):636-42. PubMed ID: 22651877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
    Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.